ADAMS ROBERT G 4
4 · NATIONAL HEALTHCARE CORP · Filed Sep 23, 2025
Insider Transaction Report
Form 4
ADAMS ROBERT G
DirectorCEO
Transactions
- Exercise/Conversion
Option to Purchase Common Stock [2021 Grant]
2025-09-19−4,500→ 0 totalExercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (4,500 underlying) - Exercise/Conversion
Shares of Common Stock - Trust I
2025-09-19$71.64/sh+4,500$322,380→ 13,579 total(indirect: By Trust)
Holdings
- 430,341(indirect: General Partner)
Shares of Common Stock - Partnership
- 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2025-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2025 Grant]
Exercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).